Developer docs
API playgroundTry for free, no card

Search company profiles

Phi-Stone

Full company profile

uuid002hggj

Namestring
Phi-Stone
Legal namestring
Phi-Stone AG
Websiteurl
phi-stone.de
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Phi-Stone AG is a Kiel, Germany-based specialty materials company that develops, manufactures, and commercializes tetrapodal zinc oxide (t-ZnO) — a zinc oxide with a unique four-armed 3D microstructure produced via a proprietary Flame Transport Synthesis (FTS) process. The company sells t-ZnO in two grades: Microbivac, a GMP-compliant pharmaceutical-grade material usable as an Active Pharmaceutical Ingredient, and a lower-cost Tech Grade t-ZnO for industrial applications such as fillers, functional additives, sensors, and optoelectronics. Phi-Stone also markets a finished consumer-facing medical product, Afinovir wound protection gel — the world's first CE-marked medical product with tetrapodal zinc oxide — and offers white-label product development services to manufacturers seeking customized hydrogel formulations.

The business model combines material sales (GMP and tech-grade t-ZnO), finished product sales (Afinovir), white-label product development fees, and collaborative research partnerships with universities and industry. Go-to-market is anchored by direct B2B enterprise sales led by a dedicated Head of Sales, supplemented by regional distribution partnerships — notably KES Pharma GmbH (cosmetics in Asian markets) and Liyfe Ltd (MENA region, distributing under the Skyn-V-Gel brand). The company is privately held, German-domiciled, founder/management-owned, and funded almost entirely through government grants (State of Schleswig-Holstein GRW and EU ERDF/BIF programs) rather than private venture capital.

Strategically, Phi-Stone is positioned as a vertically integrated materials platform pivoting from research-grade to industrial-scale GMP production following the January 2025 opening of its Flintbek facility, which has an annual capacity of up to three tonnes. Capital structure is modest (11-50 employees; no disclosed revenue or valuation), with growth underpinned by regulatory tailwinds such as the EU nano-silver ban in cosmetics, an international footprint that includes a wholly-owned Qingdao, China subsidiary, and a university research backbone via Christian-Albrechts-Universität zu Kiel (including Prof. Dr. Rainer Adelung's Chair of Functional Nanomaterials).

Short descriptiontext

Phi-Stone AG is a Kiel, Germany-based specialty materials company that produces tetrapodal zinc oxide (t-ZnO) via a proprietary Flame Transport Synthesis process, supplying GMP-grade and technical-grade t-ZnO to pharmaceutical, cosmetics, and industrial manufacturers, and marketing the CE-marked Afinovir wound protection gel for herpes.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMielkendorf, Germany
HQ citystring
Mielkendorf
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
tetrapodal zinc oxide, active pharmaceutical ingredients, antiviral wound protection, advanced materials manufacturing, cosmetic ingredient supply
NAICS code1 code
  • All Other Nonmetallic Mineral Product Manufacturing32799
SIC code1 code
  • Miscellaneous Chemical Products2890
Product category
Specialty Chemicals / Advanced Materials
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Tetrapodal Zinc Oxide (t-ZnO) Material Sales
TypeOne Time License
Description

Sale of tetrapodal zinc oxide in pharmaceutical grade (Microbivac/GMP) and technical grade for various applications in cosmetics, pharmaceuticals, and industrial products.

phi-stone.de
2Afinovir Wound Protection Gel
TypeHardware Sales
Description

Sale of proprietary finished product - wound protection gel for herpes treatment containing tetrapodal zinc oxide. CE-marked medical product launched in 2021.

phi-stone.de
3White Label / Private Label Solutions
TypeLicensing Royalties
Description

Development and supply of customized hydrogel formulations based on tetrapodal zinc oxide for partners to market under their own brand. Revenue generated through product development fees and supply of active ingredient.

phi-stone.de
4Technology Licensing and Research Partnerships
TypeProfessional Services
Description

Collaboration with research institutions and companies on publicly funded research projects. Revenue from technology transfer and co-development projects.

phi-stone.de
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details3 tiers
1GMP t-ZnO (Microbivac) for pharmaceutical/medical applications
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Quote-based pricing for pharmaceutical-grade tetrapodal zinc oxide. Available for sample orders via website contact form.

phi-stone.de
2Tech Grade t-ZnO for technical/industrial applications
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Cost-effective alternative for industrial use as filler or functional additive. Pricing available upon inquiry.

phi-stone.de
3Custom formulation and white label development
ModelOtherBilling cadenceMulti-year contract
Notes

Bespoke product development services for manufacturers seeking customized solutions. Terms negotiated on per-project basis.

phi-stone.de
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Microbivac®
Description

GMP-grade tetrapodal zinc oxide (t-ZnO) developed for medical and pharmaceutical applications. Meets highest quality requirements for medical use.

phi-stone.de
+2 more records
Core offering1 text field

Phi-Stone AG manufactures and sells tetrapodal zinc oxide (t-ZnO), a specialty zinc oxide with a unique four-armed microstructure, in two grades: pharmaceutical-grade Phi-Stone Microbivac (GMP-compliant, for medical and Active Pharmaceutical Ingredient applications) and Tech Grade t-ZnO (for technical/industrial uses). The company also markets its own finished medical product, Afinovir wound protection gel for herpes treatment, and provides white-label/custom hydrogel formulation development services to manufacturers seeking products based on t-ZnO.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Up to 3 tonnes annual production capacity
+2 more records
Product overview1 text field

Phi-Stone AG offers a portfolio of products centered on tetrapodal zinc oxide (t-ZnO), a specialized material with unique four-armed microstructure. The core offering includes Microbivac (GMP-grade t-ZnO for pharmaceutical/medical applications) and Tech Grade t-ZnO (for technical/industrial uses). The company applies this material in its consumer-facing medical product Afinovir, a wound protection gel for herpes treatment. Additionally, Phi-Stone offers private label/product development services where partners can create customized products using tetrapodal zinc oxide.

Product and service5 records
1Tetrapodal Zinc Oxide (t-ZnO)
CategorySpecialty Chemicals / Advanced Materials
Description

Tetrapodal zinc oxide with a unique four-armed microstructure providing mechanical stability and high porosity, sold in technical grade and pharmaceutical/medical grades for use in pharmaceutical, cosmetic, and industrial applications.

2Phi-Stone Microbivac
CategoryActive Pharmaceutical Ingredient
Description

GMP-grade tetrapodal zinc oxide developed to the highest quality standards for medical and pharmaceutical applications, suitable as an Active Pharmaceutical Ingredient (API) in wound protection gels, creams, powders, and ointments.

3Tech Grade t-ZnO
CategorySpecialty Chemicals / Industrial Materials
Description

Cost-effective technical-grade tetrapodal zinc oxide for industrial applications, used as a filler or functional additive in composite materials, sensor technology, optoelectronic devices, and other industrial products.

4Afinovir Wound Protection Gel
CategoryMedical Device / OTC Pharmaceutical
Description

CE-marked proprietary wound protection gel containing tetrapodal zinc oxide (Microbivac) that forms a protective barrier against herpes viruses while accelerating healing of herpes blisters via the physical viral binding mechanism; targeted at consumers seeking treatment for cold sores / herpes outbreaks.

5Private Label / Product Development Services
CategoryContract Development / White-Label Manufacturing
Description

White-label product development service enabling manufacturers to develop customized hydrogel formulations based on tetrapodal zinc oxide for marketing under their own brand, with product development fees and supply of the active ingredient.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1Christian-Albrechts-Universität zu Kiel (CAU)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-06-06
Description

Long-standing research cooperation with Kiel University for development of tetrapodal zinc oxide technology. Prof. Dr. Rainer Adelung (Chair of Functional Nanomaterials) leads fundamental research that was successfully transferred to industrial production. Partnership secured through continuous research investment and technology transfer activities.

phi-stone.de
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-01-01
Description

Distribution agreement for MENA region where Liyfe distributes products under their Skyn-V-Gel brand. Product launched at Arab Health 2024. Liyfe adapted design, packaging, leaflet, and promotional material for regional regulatory requirements and multicultural markets.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Spin-off company from Phi-Stone AG's maritime coatings research. Phi-Stone contributed biocide-free coating technology developed in cooperation with Kiel University. Clean Ocean Coatings continues development and commercialization of ecoating products for ships and yachts.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Cooperation to develop and market several cosmetic products with tetrapodal zinc oxide. KES Pharma developed innovative acne serum showing promising properties. Joint development of products for marketing in Asian region. CEO Kan Fu praised cooperation as excellent.

5University Hospital Schleswig-Holstein
Strategic tierMinorTypeStrategic or Co-development Partner
Description

R&D partnership with Prof. Dr. Ulrich Mrowietz for research cooperation. University provides clinical research expertise and academic validation for dermatological applications of tetrapodal zinc oxide.

phi-stone.de
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

German listed company commercializing antimicrobial and antiviral material technologies (silver- and zinc-based) for medical, cosmetic and industrial applications. Directly comparable to Phi-Stone in positioning as a small-cap German specialist offering novel antimicrobial material platforms, including as an alternative to banned nano-silver.

TypeBroad incumbent
Description

German-headquartered global supplier of fragrance, flavor and cosmetic active ingredients, including dermatological and skincare actives. Comparable to Phi-Stone because it sells novel functional ingredients to the same cosmetics and dermatology customers, though Symrise is far larger and diversified.

TypeDirect peer
Description

European specialist in zinc oxide and zinc powders serving cosmetics, pharmaceuticals, rubber, ceramics and electronics. Comparable to Phi-Stone as a direct competitor in the specialty zinc oxide segment, although EverZinc produces conventional ZnO rather than tetrapodal morphology and operates at much larger tonnage.

TypeBroad incumbent
Description

Global specialty ingredients supplier to the personal care, pharmaceutical and consumer health markets. Comparable to Phi-Stone as a buyer-facing supplier of innovative cosmetic and dermatological actives, but with a vastly broader ingredient portfolio and global commercial infrastructure.

TypeDirect peer
Description

North American producer of zinc oxide serving rubber, pharmaceutical, cosmetic, chemical and electronic applications. Comparable to Phi-Stone in product overlap (pharma- and cosmetic-grade ZnO) and in serving B2B customers with technical specifications, though at significantly higher production scale.

6Silox S.A.
TypeDirect peer
Description

Belgian manufacturer of zinc oxide and zinc-based specialty chemicals for pharmaceutical, cosmetic and industrial use. Direct peer to Phi-Stone as another European specialty ZnO supplier targeting pharma and personal care customers, but without the tetrapodal morphology differentiation.

7US Zinc
TypeDirect peer
Description

Major global zinc oxide producer with multiple manufacturing sites and a broad product range including pharmaceutical and cosmetic grades. Relevant peer to Phi-Stone because it competes for the same specialty ZnO customers and sets the baseline for cost and supply reliability in the market.

TypeBroad incumbent
Description

German specialty chemicals company with a significant personal care and pharmaceutical ingredients business (e.g., silica, specialty oxides). Comparable to Phi-Stone as a supplier of high-purity functional ingredients into cosmetics and pharma, with established regulatory affairs capabilities.

TypeDirect peer
Description

One of Europe's largest zinc oxide and zinc chemicals producers, headquartered in Germany. Directly comparable to Phi-Stone because it supplies both technical-grade and pharmaceutical-grade zinc oxides to the same end markets (cosmetics, pharma, industrial additives), but at vastly greater scale and with a broader product portfolio.

TypeBroad incumbent
Description

World's largest chemical company with a broad portfolio including zinc oxide, cosmetic ingredients and pharmaceutical excipients. Relevant as an incumbent that could choose to enter the specialty t-ZnO space and as a benchmark for what scale customers expect from a ZnO supplier.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Phi-Stone

Specialty Chemicals / Advanced Materialsphi-stone.de

Phi-Stone AG is a Kiel, Germany-based specialty materials company that produces tetrapodal zinc oxide (t-ZnO) via a proprietary Flame Transport Synthesis process, supplying GMP-grade and technical-grade t-ZnO to pharmaceutical, cosmetics, and industrial manufacturers, and marketing the CE-marked Afinovir wound protection gel for herpes.

What Phi-Stone does

Phi-Stone AG is a Kiel, Germany-based specialty materials company that develops, manufactures, and commercializes tetrapodal zinc oxide (t-ZnO) — a zinc oxide with a unique four-armed 3D microstructure produced via a proprietary Flame Transport Synthesis (FTS) process. The company sells t-ZnO in two grades: Microbivac, a GMP-compliant pharmaceutical-grade material usable as an Active Pharmaceutical Ingredient, and a lower-cost Tech Grade t-ZnO for industrial applications such as fillers, functional additives, sensors, and optoelectronics. Phi-Stone also markets a finished consumer-facing medical product, Afinovir wound protection gel — the world's first CE-marked medical product with tetrapodal zinc oxide — and offers white-label product development services to manufacturers seeking customized hydrogel formulations.

The business model combines material sales (GMP and tech-grade t-ZnO), finished product sales (Afinovir), white-label product development fees, and collaborative research partnerships with universities and industry. Go-to-market is anchored by direct B2B enterprise sales led by a dedicated Head of Sales, supplemented by regional distribution partnerships — notably KES Pharma GmbH (cosmetics in Asian markets) and Liyfe Ltd (MENA region, distributing under the Skyn-V-Gel brand). The company is privately held, German-domiciled, founder/management-owned, and funded almost entirely through government grants (State of Schleswig-Holstein GRW and EU ERDF/BIF programs) rather than private venture capital.

Strategically, Phi-Stone is positioned as a vertically integrated materials platform pivoting from research-grade to industrial-scale GMP production following the January 2025 opening of its Flintbek facility, which has an annual capacity of up to three tonnes. Capital structure is modest (11-50 employees; no disclosed revenue or valuation), with growth underpinned by regulatory tailwinds such as the EU nano-silver ban in cosmetics, an international footprint that includes a wholly-owned Qingdao, China subsidiary, and a university research backbone via Christian-Albrechts-Universität zu Kiel (including Prof. Dr. Rainer Adelung's Chair of Functional Nanomaterials).

Phi-Stone firmographics

Firmographics
Name
Phi-Stone
Legal name
Phi-Stone AG
Website
https://phi-stone.de
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Phi-Stone AG is a Kiel, Germany-based specialty materials company that produces tetrapodal zinc oxide (t-ZnO) via a proprietary Flame Transport Synthesis process, supplying GMP-grade and technical-grade t-ZnO to pharmaceutical, cosmetics, and industrial manufacturers, and marketing the CE-marked Afinovir wound protection gel for herpes.
Ownership category
akta.pro rank

Where Phi-Stone is headquartered

Location

Headquarters

HQ city
Mielkendorf
HQ country
Germany
HQ region
Europe

Offices4 records

Markets served

Phi-Stone business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Tetrapodal Zinc Oxide (t-ZnO) Material Sales: Sale of tetrapodal zinc oxide in pharmaceutical grade (Microbivac/GMP) and technical grade for various applications in cosmetics, pharmaceuticals, and industrial products.
  2. Afinovir Wound Protection Gel: Sale of proprietary finished product - wound protection gel for herpes treatment containing tetrapodal zinc oxide. CE-marked medical product launched in 2021.
  3. White Label / Private Label Solutions: Development and supply of customized hydrogel formulations based on tetrapodal zinc oxide for partners to market under their own brand. Revenue generated through product development fees and supply of active ingredient.
  4. Technology Licensing and Research Partnerships: Collaboration with research institutions and companies on publicly funded research projects. Revenue from technology transfer and co-development projects.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goGMP t-ZnO (Microbivac) for pharmaceutical/medical applications
Unit PricingPay-as-you-goTech Grade t-ZnO for technical/industrial applications
OtherMulti-year contractCustom formulation and white label development

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Phi-Stone product offering

Product offering

Core offering

Phi-Stone AG manufactures and sells tetrapodal zinc oxide (t-ZnO), a specialty zinc oxide with a unique four-armed microstructure, in two grades: pharmaceutical-grade Phi-Stone Microbivac (GMP-compliant, for medical and Active Pharmaceutical Ingredient applications) and Tech Grade t-ZnO (for technical/industrial uses). The company also markets its own finished medical product, Afinovir wound protection gel for herpes treatment, and provides white-label/custom hydrogel formulation development services to manufacturers seeking products based on t-ZnO.

Product overview

Phi-Stone AG offers a portfolio of products centered on tetrapodal zinc oxide (t-ZnO), a specialized material with unique four-armed microstructure. The core offering includes Microbivac (GMP-grade t-ZnO for pharmaceutical/medical applications) and Tech Grade t-ZnO (for technical/industrial uses). The company applies this material in its consumer-facing medical product Afinovir, a wound protection gel for herpes treatment. Additionally, Phi-Stone offers private label/product development services where partners can create customized products using tetrapodal zinc oxide.

Differentiator

Problem solved

Functional benefit

Brands

  • Microbivac®: GMP-grade tetrapodal zinc oxide (t-ZnO) developed for medical and pharmaceutical applications. Meets highest quality requirements for medical use.
  • Tech Grade t-ZnO
  • Afinovir®

Products and services

  • Tetrapodal Zinc Oxide (t-ZnO) Tetrapodal zinc oxide with a unique four-armed microstructure providing mechanical stability and high porosity, sold in technical grade and pharmaceutical/medical grades for use in pharmaceutical, cosmetic, and industrial applications.
  • Phi-Stone Microbivac GMP-grade tetrapodal zinc oxide developed to the highest quality standards for medical and pharmaceutical applications, suitable as an Active Pharmaceutical Ingredient (API) in wound protection gels, creams, powders, and ointments.
  • Tech Grade t-ZnO Cost-effective technical-grade tetrapodal zinc oxide for industrial applications, used as a filler or functional additive in composite materials, sensor technology, optoelectronic devices, and other industrial products.
  • Afinovir Wound Protection Gel CE-marked proprietary wound protection gel containing tetrapodal zinc oxide (Microbivac) that forms a protective barrier against herpes viruses while accelerating healing of herpes blisters via the physical viral binding mechanism; targeted at consumers seeking treatment for cold sores / herpes outbreaks.
  • Private Label / Product Development Services White-label product development service enabling manufacturers to develop customized hydrogel formulations based on tetrapodal zinc oxide for marketing under their own brand, with product development fees and supply of the active ingredient.

Quantifiable outcome

  • Up to 3 tonnes annual production capacity
  • +2 more outcomes

Companies that use Phi-Stone

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Phi-Stone technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Phi-Stone partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Christian-Albrechts-Universität zu Kiel (CAU)coreStrategic or Co-development Partner · 6 June 2024Long-standing research cooperation with Kiel University for development of tetrapodal zinc oxide technology. Prof. Dr. Rainer Adelung (Chair of Functional Nanomaterials) leads fundamental research that was successfully transferred to industrial production. Partnership secured through continuous research investment and technology transfer activities.
  • Liyfe LtdcoreChannel Partner/ Reseller/ Distributor · 1 January 2024Distribution agreement for MENA region where Liyfe distributes products under their Skyn-V-Gel brand. Product launched at Arab Health 2024. Liyfe adapted design, packaging, leaflet, and promotional material for regional regulatory requirements and multicultural markets.
  • Clean Ocean Coatings GmbHminorStrategic or Co-development Partner · 1 January 2024Spin-off company from Phi-Stone AG's maritime coatings research. Phi-Stone contributed biocide-free coating technology developed in cooperation with Kiel University. Clean Ocean Coatings continues development and commercialization of ecoating products for ships and yachts.
  • KES Pharma GmbHcoreStrategic or Co-development Partner · 1 January 2022Cooperation to develop and market several cosmetic products with tetrapodal zinc oxide. KES Pharma developed innovative acne serum showing promising properties. Joint development of products for marketing in Asian region. CEO Kan Fu praised cooperation as excellent.
  • University Hospital Schleswig-HolsteinminorStrategic or Co-development PartnerR&D partnership with Prof. Dr. Ulrich Mrowietz for research cooperation. University provides clinical research expertise and academic validation for dermatological applications of tetrapodal zinc oxide.

Scale indicators6 records

Recent moves7 records

Expansion highlights7 records

Phi-Stone competitors and assessment

Company assessment

Emerging players

  • Bio-Gate AG: German listed company commercializing antimicrobial and antiviral material technologies (silver- and zinc-based) for medical, cosmetic and industrial applications. Directly comparable to Phi-Stone in positioning as a small-cap German specialist offering novel antimicrobial material platforms, including as an alternative to banned nano-silver.

Broad incumbents

  • Symrise: German-headquartered global supplier of fragrance, flavor and cosmetic active ingredients, including dermatological and skincare actives. Comparable to Phi-Stone because it sells novel functional ingredients to the same cosmetics and dermatology customers, though Symrise is far larger and diversified.
  • Croda International: Global specialty ingredients supplier to the personal care, pharmaceutical and consumer health markets. Comparable to Phi-Stone as a buyer-facing supplier of innovative cosmetic and dermatological actives, but with a vastly broader ingredient portfolio and global commercial infrastructure.
  • Evonik: German specialty chemicals company with a significant personal care and pharmaceutical ingredients business (e.g., silica, specialty oxides). Comparable to Phi-Stone as a supplier of high-purity functional ingredients into cosmetics and pharma, with established regulatory affairs capabilities.
  • BASF: World's largest chemical company with a broad portfolio including zinc oxide, cosmetic ingredients and pharmaceutical excipients. Relevant as an incumbent that could choose to enter the specialty t-ZnO space and as a benchmark for what scale customers expect from a ZnO supplier.

Direct peers

  • EverZinc: European specialist in zinc oxide and zinc powders serving cosmetics, pharmaceuticals, rubber, ceramics and electronics. Comparable to Phi-Stone as a direct competitor in the specialty zinc oxide segment, although EverZinc produces conventional ZnO rather than tetrapodal morphology and operates at much larger tonnage.
  • Zochem: North American producer of zinc oxide serving rubber, pharmaceutical, cosmetic, chemical and electronic applications. Comparable to Phi-Stone in product overlap (pharma- and cosmetic-grade ZnO) and in serving B2B customers with technical specifications, though at significantly higher production scale.
  • Silox S.A. Belgian manufacturer of zinc oxide and zinc-based specialty chemicals for pharmaceutical, cosmetic and industrial use. Direct peer to Phi-Stone as another European specialty ZnO supplier targeting pharma and personal care customers, but without the tetrapodal morphology differentiation.
  • US Zinc: Major global zinc oxide producer with multiple manufacturing sites and a broad product range including pharmaceutical and cosmetic grades. Relevant peer to Phi-Stone because it competes for the same specialty ZnO customers and sets the baseline for cost and supply reliability in the market.
  • Grillo-Werke AG: One of Europe's largest zinc oxide and zinc chemicals producers, headquartered in Germany. Directly comparable to Phi-Stone because it supplies both technical-grade and pharmaceutical-grade zinc oxides to the same end markets (cosmetics, pharma, industrial additives), but at vastly greater scale and with a broader product portfolio.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Phi-Stone social profiles

Digital presence

Phi-Stone compliance and trust

Trust signal

Compliance1 record

Phi-Stone financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Phi-Stone leadership team

Management profile

Number of profiles

Profiles7 records

Phi-Stone subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Phi-Stone funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Phi-Stone M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Phi-Stone

What does Phi-Stone do?

Phi-Stone AG manufactures and sells tetrapodal zinc oxide (t-ZnO), a specialty zinc oxide with a unique four-armed microstructure, in two grades: pharmaceutical-grade Phi-Stone Microbivac (GMP-compliant, for medical and Active Pharmaceutical Ingredient applications) and Tech Grade t-ZnO (for technical/industrial uses). The company also markets its own finished medical product, Afinovir wound protection gel for herpes treatment, and provides white-label/custom hydrogel formulation development services to manufacturers seeking products based on t-ZnO.

Is Phi-Stone a public or private company?

Phi-Stone is a private company. It is classified as management employee owned and is currently operating.

When was Phi-Stone founded?

Phi-Stone was founded in 2017. It employs 11 to 50 people.

Where is Phi-Stone based?

Phi-Stone is headquartered in Mielkendorf, Germany, in the Europe region.

How does Phi-Stone make money?

Four revenue lines are on record. Tetrapodal Zinc Oxide (t-ZnO) Material Sales are the primary driver. The others are afinovir Wound Protection Gel, white Label / Private Label Solutions and technology Licensing and Research Partnerships.

Who are Phi-Stone's main competitors?

Bio-Gate AG is listed as an emerging player. Broad incumbents are Symrise, Croda International, Evonik and BASF. Direct peers are EverZinc, Zochem, Silox S.A., US Zinc and Grillo-Werke AG.

Does Phi-Stone have an API?

No public API is recorded for Phi-Stone.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales